Literature DB >> 3336380

Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking.

P Tønnesen1, V Fryd, M Hansen, J Helsted, A B Gunnersen, H Forchammer, M Stockner.   

Abstract

We studied the effectiveness of chewing gum containing nicotine, in combination with group counseling, for subjects who were attempting to stop smoking. We used the Horn-Russell scale, based on a smoking questionnaire, to measure dependence on cigarettes; 173 smokers were grouped as highly dependent on nicotine or as having medium to low degrees of dependence. In a randomized double-blind study, the 60 highly dependent smokers were given gum containing 4 mg of nicotine (n = 27) or 2 mg of nicotine (n = 33), and the 113 smokers with medium or low dependence were given gum containing 2 mg of nicotine (n = 60) or a placebo gum (n = 53). All smokers took part in group counseling. In the highly dependent group, abstinence from cigarettes was chemically verified after six weeks, one year, and two years; 81.5 percent, 44.4 percent, and 33.3 percent of the subjects given gum containing 4 mg of nicotine were abstinent after those follow-up periods; the rates of abstinence were 54.5 percent, 12.1 percent, and 6.1 percent, respectively, for the subjects given gum containing 2 mg of nicotine. In the group with medium or low dependence, the rates of abstinence after the same periods were 73.3 percent, 38.3 percent, and 28.3 percent for the subjects given gum containing 2 mg of nicotine and 41.5 percent, 22.6 percent, and 9.4 percent for those given placebo gum. The differences in outcomes were significant at the 5 percent level for all comparisons, with the exception of the 2-mg nicotine gum versus the placebo gum at one year. This study indicates that the effectiveness of nicotine gum is not due to a placebo effect and that it is related to dose. The use of nicotine gum in appropriate doses should be helpful to persons who are attempting to stop smoking.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3336380     DOI: 10.1056/NEJM198801073180104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  41 in total

1.  Effect of nicotine, silver acetate, and ordinary chewing gum in combination with group counselling on smoking cessation.

Authors:  E J Jensen; E Schmidt; B Pedersen; R Dahl
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

2.  Smoke-free Europe in the year 2000: nongovernmental action (smoking cessation treatment).

Authors:  M Kunze
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 3.  Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire.

Authors:  K O Fagerstrom; N G Schneider
Journal:  J Behav Med       Date:  1989-04

4.  Training physicians about smoking cessation: a controlled trial in private practice.

Authors:  S R Cummings; R J Richard; C L Duncan; B Hansen; R Vander Martin; B Gerbert; T J Coates
Journal:  J Gen Intern Med       Date:  1989 Nov-Dec       Impact factor: 5.128

5.  Smokeless tobacco abstinence effects and nicotine gum dose.

Authors:  D Hatsukami; D Anton; R Keenan; A Callies
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

6.  Efficacy of bupropion alone and in combination with nicotine gum.

Authors:  Megan E Piper; E Belle Federman; Danielle E McCarthy; Daniel M Bolt; Stevens S Smith; Michael C Fiore; Timothy B Baker
Journal:  Nicotine Tob Res       Date:  2007-09       Impact factor: 4.244

7.  Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.

Authors:  Edward J Mills; Kristian Thorlund; Shawn Eapen; Ping Wu; Judith J Prochaska
Journal:  Circulation       Date:  2013-12-09       Impact factor: 29.690

8.  Effectiveness of nicotine patch and nicotine gum as individual versus combined treatments for tobacco withdrawal symptoms.

Authors:  K O Fagerström; N G Schneider; E Lunell
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Nicotine polacrilex dose effects: serum nicotine levels and sensory characteristics.

Authors:  S J Leischow; D P Sachs; M D Hansen; A G Bostrom
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

Review 10.  The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.

Authors:  S G Gourlay; N L Benowitz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.